BACKGROUND To determine whether women with extremely low-serum anti-Mullerian
hormone (AMH) levels (< 0.1–0.4 ng/ml) still demonstrate live birth potential with assisted …

The aim of the present study was to investigate the clinical pregnancy and live birth rates in
women with extremely low (⩽ 0.4 ng/ml) anti-Müllerian hormone (AMH) concentrations. The …

Purpose The aims of this study were to assess the outcome of in vitro fertilization (IVF) in
women with very low circulating anti-müllerian hormone (AMH) and to investigate factors …

Background The age-specific definition of low anti-müllerian hormone (AMH) is lacking. This
study aims to define an age-specific reference for low AMH and to evaluate the associated …

Objective: The objective of the study was to evaluate whether anti-Müllerian hormone (AMH)
is associated with fecundability among women with proven fecundity and a history of …

Research question Is anti-Müllerian hormone (AMH) serum concentration a useful tool to
predict the outcome of assisted reproductive treatment? Design Retrospective cohort study …

Background The number of unintentionally childless couples is increasing as more couples
seek to conceive for the first time in the third or fourth decade of the woman's life …

STUDY QUESTION Is a low (< 1.0 μg/L) or moderately low (1.0–1.9 μg/L) serum anti-
Müllerian hormone (AMH) level a risk factor for early pregnancy loss in IVF/ICSI with a fresh …

The conflicting results from studies on the predictive capabilities of serum anti-Müllerian
hormone (AMH) for IVF pregnancy outcomes may be attributed to small sample sizes and …

Purpose To evaluate the role of Anti-mullerian hormone (AMH) in predicting cumulative
pregnancy outcome during in-vitro fertilization (IVF) treatment. Methods Serum AMH levels …